📊 SRXH Key Takeaways
Is SRx Health Solutions, Inc. (SRXH) a Good Investment?
SRx Health Solutions exhibits critically unsustainable unit economics with $6.2M revenue unable to support ~$11M operating expenses, generating -$9.6M free cash flow annually. At current burn rates, the company's $20.5M cash position provides only ~2 years of runway without dramatic operational turnaround or capital infusion.
SRx Health Solutions, Inc. Key Strengths (SRXH)
- Zero long-term debt eliminates refinancing and debt service risks
- Current cash position of $20.5M provides near-term operational runway
- Gross margin of 37.3% suggests underlying product economics may be viable if scale achieved
SRXH Stock Risks: SRx Health Solutions, Inc. Investment Risks
- Negative free cash flow of -$9.6M is unsustainable and depletes cash reserves at ~2-year runway
- Revenue of $6.2M cannot support $11.2M in operating expenses, indicating fundamental business model failure
- Operating loss of -$5.6M and net margin of -240.1% demonstrate severe profitability collapse
- ROE of -82.0% and ROA of -34.6% show value destruction across all shareholder/asset metrics
- Minimal insider activity (2 Form 4 filings in 90 days) suggests lack of insider confidence
- Capital requirements appear to exceed cash reserves without significant revenue inflection
Key Metrics to Watch
- Quarterly revenue growth trajectory - needs inflection to extend runway
- Operating cash flow improvement - most critical indicator of sustainability
- Operating expense reduction - cost structure must align with revenue base
- Cash balance depletion rate - tracks path to potential insolvency
- Any debt issuance or capital raise announcements indicating liquidity pressure
SRx Health Solutions, Inc. (SRXH) Financial Metrics & Key Ratios
💡 AI Analyst Insight
SRx Health Solutions, Inc. presents a mixed fundamental picture. Review the detailed metrics above to form your own investment thesis.
SRXH Profit Margin, ROE & Profitability Analysis
SRXH vs Consumer Sector: How SRx Health Solutions, Inc. Compares
How SRx Health Solutions, Inc. compares to Consumer sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
Is SRx Health Solutions, Inc. Stock Overvalued? SRXH Valuation Analysis 2026
Based on fundamental analysis, SRx Health Solutions, Inc. has mixed fundamental signals relative to the Consumer sector in 2026.
Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.
SRx Health Solutions, Inc. Balance Sheet: SRXH Debt, Cash & Liquidity
SRXH Revenue & Earnings Growth: 5-Year Financial Trend
5-Year Trend Summary: SRx Health Solutions, Inc.'s revenue has declined by 86% over the 5-year period, indicating business contraction. The most recent EPS of $-1.95 indicates the company is currently unprofitable.
SRXH Revenue Growth, EPS Growth & YoY Performance
SRXH Quarterly Earnings & Performance
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q2 2026 | $3.4M | -$4.0M | $-0.02 |
| Q1 2026 | $2.8M | -$4.0M | $-0.17 |
| Q3 2025 | $11.4M | -$3.1M | $-0.14 |
| Q1 2025 | $7.2M | -$964.0K | $-0.37 |
| Q3 2024 | $2.0M | $1.3M | $0.73 |
| Q2 2024 | $8.5M | -$176.0K | $-0.21 |
| Q1 2024 | $7.9M | -$2.8M | $-3.60 |
| Q3 2023 | $11.9M | -$1.6M | $-0.05 |
Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.
SRx Health Solutions, Inc. Dividends, Buybacks & Capital Allocation
SRXH SEC Filings: Latest 10-K & 10-Q Analysis
Access official SEC EDGAR filings for SRx Health Solutions, Inc. (CIK: 0001471727)
📋 Recent SEC Filings
❓ Frequently Asked Questions about SRXH
What is the AI rating for SRXH?
SRx Health Solutions, Inc. (SRXH) has an AI grade of D with 96% confidence, based on fundamental analysis of SEC EDGAR filings.
What are SRXH's key strengths?
Claude: Zero long-term debt eliminates refinancing and debt service risks. Current cash position of $20.5M provides near-term operational runway.
What are the risks of investing in SRXH?
Claude: Negative free cash flow of -$9.6M is unsustainable and depletes cash reserves at ~2-year runway. Revenue of $6.2M cannot support $11.2M in operating expenses, indicating fundamental business model failure.
What is SRXH's revenue and growth?
SRx Health Solutions, Inc. reported revenue of $6.2M.
Does SRXH pay dividends?
SRx Health Solutions, Inc. does not currently pay dividends.
Where can I find SRXH SEC filings?
Official SEC filings for SRx Health Solutions, Inc. (CIK: 0001471727) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is SRXH's EPS?
SRx Health Solutions, Inc. has a diluted EPS of $-0.09.
How is the AI analysis conducted?
Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined grade reflects both perspectives for balanced insights.
What is SRXH's fundamental grade?
Based on our AI fundamental analysis in May 2026, SRx Health Solutions, Inc. has a D grade with 96% confidence. Review the strengths and risks sections above for full context. This is not investment advice.
Is SRXH stock overvalued or undervalued?
Valuation metrics for SRXH: ROE of -82.0% (sector avg: 18%), net margin of -240.1% (sector avg: 8%). Compare these metrics with sector averages to assess valuation.
What is SRXH's AI grade for 2026?
Our dual AI analysis gives SRx Health Solutions, Inc. a combined D grade for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.
What is SRXH's free cash flow?
SRx Health Solutions, Inc.'s operating cash flow is $-9.5M, with capital expenditures of $7.0K. FCF margin is -153.0%.
How does SRXH compare to other Consumer stocks?
Vs Consumer sector averages: Net margin -240.1% (avg: 8%), ROE -82.0% (avg: 18%), current ratio 1.72 (avg: 1.5).